Skip to content
Back to Blog
Smart Factory
2026-04-278 min read20

AI Application Rapid Commercialization — Strategy for Manufacturing AI R&D KRW 68.1B Fund

A comprehensive guide to leveraging the new 2026 AI Application Rapid Commercialization Program's KRW 68.1B R&D fund — eligibility, evaluation criteria, cost structure, and proposal-writing strategies based on KITIM consulting expertise.

KITIM Consulting Team

Program Overview and Policy Background

The AI Application Rapid Commercialization Program launches in 2026 as a new track within the Smart Manufacturing Innovation Integrated Notice. Jointly led by the Ministry of SMEs and Startups (MSS) and the Ministry of Science and ICT (MSIT), this program injects KRW 68.1 billion into manufacturing AI solution and equipment R&D, accelerating commercialization of AI technologies immediately deployable on Korean manufacturing floors.

Policy Drivers

  • Manufacturing digital transformation urgency: Response to declining workforce and rising labor costs
  • AI application market leadership: Global manufacturing AI market projected at USD 20B by 2027
  • Inter-ministry collaboration: MSS (commercialization) + MSIT (core technology, validation)
  • Multi-year roadmap: KRW 68.1B in 2026, scaling to KRW 200B cumulative by 2028
  • Unlike conventional R&D programs that end at technology development, this initiative provides a full-cycle package covering development, validation, commercialization, and revenue generation.

    Eligibility and Core Requirements

    Applicant Qualifications

  • Companies with AI application products: Solution, equipment, or software at prototype stage or beyond
  • SMEs and mid-sized firms in development: Core algorithms secured, commercialization viable within 12 months
  • Consortiums recommended: Manufacturing AI suppliers + demand-side manufacturers
  • Evaluation Criteria

  • Manufacturing applicability (30 pts): Process integration feasibility, interface compatibility
  • Commercialization speed (25 pts): Revenue generation within 12 months
  • Market potential and differentiation (20 pts): Competitive advantage, entry barriers
  • Technology readiness (15 pts): TRL 6 or higher recommended
  • Commercialization infrastructure (10 pts): Sales, CS, follow-on development staff
  • Self-Development vs Joint Development Tracks

  • Self-Development Track: Up to KRW 500M, 1-year, supplier alone
  • Joint Development Track: Up to KRW 1B, 1.5 years, supplier+demand consortium (5-pt bonus)
  • Funding Scale and Cost-Sharing

    Per-Project Funding Limits

  • Self-Development: Government grant up to KRW 500M, private match 25%+
  • Joint Development: Government grant up to KRW 1B, private match 33%+ (10% cash)
  • 80–100 projects expected from total KRW 68.1B pool
  • Eligible Cost Categories

  • Personnel: Internal researchers up to 50%, new hires preferred
  • Equipment and materials: GPUs, edge devices for AI training, validation materials
  • Subcontracted research: Up to 30% for university/government lab consortiums
  • Indirect costs: Up to 17% of recognized direct costs
  • Revenue-Linked Recovery and Royalty Structure

  • Royalty: 10% (SMEs) to 20% (mid-sized) of grant, 5-year installment
  • Revenue-linked recovery: Additional recovery if cumulative revenue exceeds KRW 5B within 3 years post-completion
  • Success/failure determination: 70%+ revenue target achievement = success
  • Proposal Writing Strategies for Higher Selection Rates

    Market and Rapid Commercialization Evidence

  • Target market sizing: TAM/SAM/SOM analysis with domestic manufacturing AI market share goals
  • Customer LOIs: Letters of intent from 3+ prospective demand-side firms
  • Competitive analysis: Feature and price comparison of 5+ competing solutions
  • Manufacturing Reference and PoC Results

  • Existing PoC data: Quantified metrics — XX% process efficiency improvement, XX% defect reduction
  • Pilot deployment cases: Trial operations with 1–2 partner companies
  • Scalability evidence: Cross-industry application potential of the same solution
  • KPI Setting Guide

  • Revenue targets: Year 1 KRW 500M, Year 2 KRW 1.5B, Year 3 KRW 3B — staged presentation
  • Process efficiency: 30% cycle time reduction, 15% OEE improvement
  • Quality improvement: 50% defect reduction, 99%+ inspection accuracy
  • Customer acquisition: 10+ paying customers by program completion
  • Leveraging KITIM R&D Consulting

    KITIM brings deep expertise in manufacturing AI R&D consulting, including the AI Application Rapid Commercialization Program.

    Consulting Service Scope

  • Pre-application fit assessment: TRL evaluation + supplier/demand track recommendation
  • Linked program identification: Smart Manufacturing Innovation Center, DIH, AI Voucher follow-on matching
  • Proposal review and refinement: Bonus point optimization per evaluation criteria, quantitative KPI design
  • Pitch coaching: Mentoring by former evaluators, 2+ mock presentations
  • Post-selection project management: Annual evaluation, settlement, royalty payment support
  • Follow-on program connection: TIPS, Deep-Tech TIPS, global expansion programs
  • Three factors determine selection: market potential, commercialization speed, and quantitative KPIs. With 500+ consulting projects and an average 65%+ R&D selection rate, KITIM helps your company secure its share of the KRW 68.1B fund. Request your [free consultation](/contact) today.

    AI ApplicationRapid CommercializationManufacturing AIR&DSmart Manufacturing Innovation

    Related Posts

    Bio

    Biologics Approval Fees Rise From KRW 8.03M to 20.71M, Data-Submission Drugs About 6x — MFDS Fee Regulation Amendment Pre-Announced Nov 6, 2026 (Comments Due Nov 26 / Dec 16): Filing Timing, Budget Review and Fee-Reduction Checks for Pharma & Bio SMEs

    Under the fee amendment MFDS proposed on November 6, approval fees for new biologics would rise from KRW 8.03 million to KRW 20.71 million, and fees for data-submission drugs would go up about sixfold. This guide shows pharma and bio SMEs how to review their filing timing, budgets, fee-reduction eligibility and public comments.

    2026-11-09
    Management Consulting

    Factories With 20–49 Workers Will Need a Safety or Health Manager — Korea's First Tripartite Agreement on November 5 (About 30,000 Sites in 5 Industries Including Manufacturing, Decree Amendment in 2027, Target Start 2028), the Owner-Led Alternative and Government Payroll Support: A Preparation Guide for Small Manufacturers

    Under Korea's November 5 tripartite agreement, about 30,000 sites with 20–49 workers in manufacturing and four other industries are expected to need a qualified safety or health manager from 2028. This guide covers what is settled and what is still open, the owner-led alternative, a cost comparison, and a preparation checklist.

    2026-11-09
    Government Programs

    SMEs Can Now Enter the KRW 1,500 Trillion 'Mega Project' Supply Chain from the Design Stage — MSS Joins as a Lead Ministry, Large/Mid-Tier–SME Councils and Regional Councils Launch (Nov 6 Plan to Expand Planning-Stage Participation), and How SMEs Targeting Semiconductor, AI Data Center and Physical AI Supply Chains Should Prepare Validation, Certification and Mass-Production Qualification

    MSS has joined Korea's KRW 1,500 trillion mega projects as a lead ministry and plans to bring SMEs in from the planning stage. This guide covers how the central and regional councils will work and how to line up support programs against the validation, certification and mass-production barriers.

    2026-11-09
    Updated daily

    Let AI find government support programs in this field

    Complete a 3-minute company assessment and we will recommend programs that fit your company, each with a match score. It is free.

    Get AI-Matched Programs for Free

    Need Consulting?

    Our technology innovation consultants will propose the optimal solution for your company.